Looking to expand your partner network with leading companies like Novabiotics? Consider joining Inpart's global network for free.
In Depth 11 Jan 2023
Drug repurposing emerges as viable option for rare disease treatment
With few options available for the treatment of rare diseases, the practice of drug repurposing has gained traction as an effective strategy. With genome sequencing revealing new rare diseases, it is now known that at least 5% of the world population lives with a rare disease. Drug development must pick up the pace to keep […]
